Sign Up to like & get
recommendations!
0
Published in 2021 at "Current pharmaceutical design"
DOI: 10.2174/1381612827666210610114029
Abstract: Metabolic syndrome (MetS) represents a cluster of metabolic disorders that arise from insulin resistance (IR) and adipose tissue dysfunction. As a consequence, there is an increased risk for type 2 diabetes mellitus and atherosclerotic cardiovascular…
read more here.
Keywords:
myocardial infarction;
prevalence mets;
metabolic syndrome;
syndrome myocardial ... See more keywords